# Silo Pharma, Inc.: Form 8-K, filed Jun 6, 2024

- Company: [Silo Pharma, Inc.](/companies/silo.md) (CIK 1514183)
- Form: 8-K
- Filed: 2024-06-06
- Accepted by EDGAR: Jun 6, 2024, 16:52 ET
- Period: 2024-06-04
- Accession: 0001213900-24-050405
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1514183/000121390024050405/ea0207381-8k_silo.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1514183/000121390024050405/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1514183/000121390024050405/ea0207381-8k_silo.htm

Filed Jun 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-050405. Last ingested by Listed: Nov 6, 2026, 18:16 ET. No prices; not investment advice.